Go Pro

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare logo
$200.50 -0.30 (-0.15%)
As of 09/4/2026 03:58 PM Eastern

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
12
Buy
3

Based on 17 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 12 have given a hold rating, and 3 have given a buy rating for MOH.

Consensus Price Target

$202.44
0.97% Upside
According to the 17 analysts' twelve-month price targets for Molina Healthcare, the average price target is $202.44. The highest price target for MOH is $286.00, while the lowest price target for MOH is $124.00. The average price target represents a forecasted upside of 0.97% from the current price of $200.50.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOH Analyst Ratings Over Time

TypeCurrent Forecast
9/8/25 to 9/8/26
1 Month Ago
8/9/25 to 8/9/26
3 Months Ago
6/10/25 to 6/10/26
1 Year Ago
9/8/24 to 9/8/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
12 Hold rating(s)
11 Hold rating(s)
11 Hold rating(s)
9 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$202.44$202.44$182.73$225.18
Forecasted Upside0.97% Upside2.94% Upside-7.69% Downside28.40% Upside
Consensus RatingHoldHoldHoldHold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Molina Healthcare Stock vs. The Competition

TypeMolina HealthcareHealthcare CompaniesBroader Market
Consensus Rating Score
2.06
2.30
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside0.97% Upside928.67% Upside14.04% Upside
News Sentiment Rating
Positive News

See Recent MOH News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/4/2026
Cantor Fitzgerald logo
Cantor Fitzgerald
5 of 5 stars
Sarah James
Sarah James
3 of 5 stars
Reiterated RatingNeutral
8/26/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 DowngradeSell (D+)Sell (D)
8/21/2026
Zacks Research logo
Zacks Research
5 of 5 stars
 DowngradeStrong-BuyHold
7/28/2026Lower TargetEqual Weight$235.00 ➝ $220.00+10.07%
7/24/2026Lower TargetUnderweight$184.00 ➝ $180.00-10.14%
7/24/2026Lower TargetHold$250.00 ➝ $225.00+15.42%
7/24/2026Lower TargetSector Perform$248.00 ➝ $218.00+10.45%
7/14/2026 Set Target$230.00-5.06%
7/14/2026Boost TargetHold$163.00 ➝ $230.00-5.48%
7/13/2026 Set Target$286.00+19.75%
SpaceX Was Overvalued. This Asset Isn't. (Ad)

SpaceX lost 26% of its value in days, wiping out $50 billion of Elon Musk's net worth. Morningstar had flagged the IPO as overvalued by nearly half before the offering even settled. Preserve Gold's free 2026 Gold and Silver Kit shows how to move part of an eligible 401(k) or IRA into physical gold or silver, tax and penalty free, backed by a price-match guarantee and no-fee buybacks.tc pixel

Get your free Precious Metals Guide today
6/8/2026 Set Target$215.00+10.89%
6/8/2026Boost TargetNeutral$169.00 ➝ $191.00-2.77%
6/4/2026Boost TargetEqual Weight$146.00 ➝ $167.00-12.83%
5/22/2026Boost TargetNeutral$180.00 ➝ $202.00+11.67%
5/11/2026Boost TargetNeutral$124.00 ➝ $163.00-12.40%
4/29/2026 UpgradeUnderperformBuy$250.00+34.76%
4/24/2026 Reiterated RatingHold$129.00-23.33%
2/11/2026Lower TargetNeutral$167.00 ➝ $124.00+1.10%
4/9/2025Initiated CoverageNeutral
2/6/2025Reiterated RatingEqual Weight$345.00 ➝ $345.00+19.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:23 AM ET.


Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 6, 2026. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

  • Molina Healthcare, Inc. recently demonstrated strong earnings performance by reporting $1.51 in earnings per share for the quarter ended July 22, 2026, which beat the analyst consensus estimate of $1.39 by $0.12, indicating that the company is generating more profit per share than expected by the market.
  • The stock is currently trading at $200.50, which is below the consensus price target of $202.44 set by analysts, suggesting that the current market price may be undervalued relative to the average expectation for future growth and potential upside.
  • Institutional investors are showing renewed interest in the company, with Public Employees Retirement System of Ohio purchasing a new stake of 16,018 shares valued at approximately $3.66 million during the second quarter, signaling confidence from large, long-term investors in the company's stability and outlook.
  • Molina Healthcare, Inc. has a beta of 0.75, which is lower than the market average of 1.0, meaning the stock tends to be less volatile than the overall market and may provide a more stable investment option for those seeking to reduce portfolio risk.
  • The company has a current ratio of 1.68 and a quick ratio of 1.68, both of which are above 1.0, indicating that Molina Healthcare, Inc. has sufficient liquid assets to cover its short-term liabilities, which is a positive sign of financial health and liquidity management.

Molina Healthcare
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

  • Molina Healthcare, Inc. has a negative P/E ratio of -1,113.83, which indicates that the company is currently reporting a net loss or has negative earnings, making it difficult to value the stock using traditional earnings-based metrics and suggesting potential profitability challenges.
  • The company's revenue declined by 4.8% on a year-over-year basis in the most recent quarter, falling to $10.87 billion, which suggests a slowdown in top-line growth and could impact future earnings if the trend continues.
  • Molina Healthcare, Inc. has a negative net margin of 0.02%, meaning that for every dollar of revenue, the company is losing a fraction of a cent, which indicates that its operating costs are currently exceeding its revenue, a concerning sign for profitability.
  • The stock has a 50-day simple moving average of $211.38, which is higher than the current price of $200.50, suggesting that the stock is trading below its short-term trend and may be under pressure from recent selling activity.
  • Molina Healthcare, Inc. has a debt-to-equity ratio of 0.95, which is relatively high and indicates that the company is using a significant amount of debt to finance its operations, which could increase financial risk and interest expenses, especially if interest rates rise or earnings decline.

MOH Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $202.44, with a high forecast of $286.00 and a low forecast of $124.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last year. There are currently 2 sell ratings, 12 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted upside of 0.97% based on their 12-month stock forecasts.

Over the previous 90 days, Molina Healthcare's stock had 3 downgrades and 2 upgrades by analysts.

Analysts like Molina Healthcare less than other "healthcare" companies. The consensus rating score for Molina Healthcare is 2.06 while the average consensus rating score for "healthcare" companies is 2.30. Learn more on how MOH compares to other companies.


MarketBeat monitors more than a dozen sources for Molina Healthcare analyst ratings, with the most recent rating issued on 9/4/2026.
From Our Partners